N A Malkova

591 total citations
28 papers, 69 citations indexed

About

N A Malkova is a scholar working on Pathology and Forensic Medicine, Neurology and Rheumatology. According to data from OpenAlex, N A Malkova has authored 28 papers receiving a total of 69 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pathology and Forensic Medicine, 6 papers in Neurology and 6 papers in Rheumatology. Recurrent topics in N A Malkova's work include Multiple Sclerosis Research Studies (22 papers), Fibromyalgia and Chronic Fatigue Syndrome Research (4 papers) and Systemic Lupus Erythematosus Research (4 papers). N A Malkova is often cited by papers focused on Multiple Sclerosis Research Studies (22 papers), Fibromyalgia and Chronic Fatigue Syndrome Research (4 papers) and Systemic Lupus Erythematosus Research (4 papers). N A Malkova collaborates with scholars based in Russia, United States and Belarus. N A Malkova's co-authors include С А Сиверцева, D. S. Korobko, М. Н. Захарова, Е. В. Попова, Galina Salogub, Ф. А. Хабиров, Н. А. Спирин, Roman Ivanov, E. P. Evdoshenko and Elena Zakharova and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Immunogenetics.

In The Last Decade

N A Malkova

23 papers receiving 68 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
N A Malkova Russia 6 56 32 15 8 8 28 69
Pierre Grammond Australia 4 89 1.6× 29 0.9× 34 2.3× 21 2.6× 9 1.1× 6 96
Patti Tosta Lebanon 2 13 0.2× 9 0.3× 8 0.5× 9 1.1× 24 3.0× 2 45
Sam Yuen Australia 4 35 0.6× 37 1.2× 6 0.4× 5 0.6× 8 52
Magda Alexis France 4 33 0.6× 36 1.1× 6 0.4× 1 0.1× 3 0.4× 9 57
Amanda Gillespie-Twardy United States 4 23 0.4× 23 0.7× 5 0.3× 1 0.1× 4 0.5× 8 45
Robert Galamaga United States 3 31 0.6× 23 0.7× 5 0.3× 16 2.0× 5 39
Meredith Little United States 4 43 0.8× 18 0.6× 4 0.3× 24 3.0× 8 67
Sophy Denker Germany 4 23 0.4× 20 0.6× 3 0.2× 4 0.5× 5 35
Barbara Pro United Kingdom 3 31 0.6× 20 0.6× 16 1.1× 7 0.9× 4 40
Sven Mattern Germany 4 8 0.1× 18 0.6× 5 0.3× 3 0.4× 6 0.8× 13 39

Countries citing papers authored by N A Malkova

Since Specialization
Citations

This map shows the geographic impact of N A Malkova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N A Malkova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N A Malkova more than expected).

Fields of papers citing papers by N A Malkova

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N A Malkova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N A Malkova. The network helps show where N A Malkova may publish in the future.

Co-authorship network of co-authors of N A Malkova

This figure shows the co-authorship network connecting the top 25 collaborators of N A Malkova. A scholar is included among the top collaborators of N A Malkova based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N A Malkova. N A Malkova is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Korobko, D. S., et al.. (2024). Multiple sclerosis: modern diagnostic markers and prognostic factors of disease progression. SHILAP Revista de lepidopterología. 44(1). 39–51. 1 indexed citations
2.
Malkova, N A, et al.. (2023). EVALUATION OF THE TELETSKOYE LAKE WATER QUALITY FOR ITS USABILITY FOR IRRIGATION AND AGRICULTURAL WATER SUPPLY IN THE BIYA RIVER BASIN. Vestnik Altajskogo gosudarstvennogo agrarnogo universiteta. 229(11). 50–55. 1 indexed citations
3.
Malkova, N A, С А Сиверцева, N. А. Totolyan, et al.. (2023). Long-term Efficacy and Safety of Sampeginterferon-β1a in the Treatment of Relapsing Remitting Multiple Sclerosis: a Randomized, Double-Blind Clinical Trial 104-Week Results. S S Korsakov Journal of Neurology and Psychiatry. 123(2). 52–52. 2 indexed citations
4.
Фурсова, А. Ж., et al.. (2023). Modern diagnostic potentials of studying structural and functional changes of the retina and the optic nerve in multiple sclerosis patients. Russian Ophthalmological Journal. 16(4). 97–104.
5.
Хайбуллин, Т И, et al.. (2022). Results of a study of the quality of life in patients with highly active multiple sclerosis in Russia. SHILAP Revista de lepidopterología. 14(1S). 9–15. 1 indexed citations
6.
Гусев, Е. И., et al.. (2022). Efficacy and safety of sampeginterferon β-1a in the treatment of relapsing remitting multiple sclerosis: results of 52 weeks of therapy in a randomized, double-blind clinical trial. S S Korsakov Journal of Neurology and Psychiatry. 122(1). 62–62. 6 indexed citations
7.
Brylev, Lev, М. Н. Захарова, D. S. Korobko, et al.. (2021). Consensus of expert advices on routing, diagnosis, and management of patients with neuromyelitis optica spectrum disorders. SHILAP Revista de lepidopterología. 13(5). 140–147. 1 indexed citations
8.
Evdoshenko, E. P., N A Malkova, Odinak Mm, et al.. (2019). The efficacy and safety of siponimod in the Russian population of patients with secondary progressive multiple sclerosis. S S Korsakov Journal of Neurology and Psychiatry. 119(10). 110–110.
9.
Malkova, N A, et al.. (2019). The new pegylated interferon beta-1a (sampeginterferon beta-1a, BCD-054) in the treatment of remitting multiple sclerosis. S S Korsakov Journal of Neurology and Psychiatry. 119(10). 100–100. 2 indexed citations
10.
Evdoshenko, E. P., Е. В. Попова, С А Сиверцева, et al.. (2019). Real-world study of efficacy, risk management and reasons for discontinuation of natalizumab for treatment of multiple sclerosis in Russia. PLoS ONE. 14(5). e0217303–e0217303. 6 indexed citations
11.
Malkova, N A, et al.. (2019). Susac syndrome, review and clinical case. S S Korsakov Journal of Neurology and Psychiatry. 119(2). 52–52. 1 indexed citations
12.
Попова, Е. В., et al.. (2018). Primary-progressive multiple sclerosis in Russia: a medical-sociological study involving patients and neurologists. S S Korsakov Journal of Neurology and Psychiatry. 118(8). 40–40. 5 indexed citations
13.
Evdoshenko, E. P., М. Н. Захарова, N A Malkova, et al.. (2018). Provision of alemtuzumab safety is one of the main components of pharmacovigilance. S S Korsakov Journal of Neurology and Psychiatry. 118(8). 82–82. 4 indexed citations
14.
Алифирова, В. М., М. Н. Захарова, Elena Zakharova, et al.. (2017). Clinical recommendations on the use of alemtuzumab (lemtrada). S S Korsakov Journal of Neurology and Psychiatry. 117(2. Vyp. 2). 115–115. 7 indexed citations
15.
Попова, Е. В., И. С. Киселев, С А Сиверцева, et al.. (2017). Polymorphic variants of the immune response genes as risk factors for primary progressive multiple sclerosis. S S Korsakov Journal of Neurology and Psychiatry. 117(2. Vyp. 2). 14–14. 2 indexed citations
16.
Попова, Е. В., Anna N. Belova, N A Malkova, et al.. (2017). Primary progressive multiple sclerosis: current issues of timely diagnosis. S S Korsakov Journal of Neurology and Psychiatry. 117(10). 35–35. 2 indexed citations
17.
Алифирова, В. М., А. Н. Бойко, М. Н. Захарова, et al.. (2017). Clinical guidelines for the use of dimethyl fumarate in relapsing-remitting multiple sclerosis. S S Korsakov Journal of Neurology and Psychiatry. 117(1). 97–97. 1 indexed citations
18.
Evdoshenko, E. P., И. П. Пронин, А. Н. Бойко, et al.. (2016). Recommendations on the algorithms for drug choice and risk management plan in the treatment of patients with remitting multiple sclerosis with natalizumab. S S Korsakov Journal of Neurology and Psychiatry. 116(10. Vyp. 2). 79–79. 6 indexed citations
19.
Morozova, Vera V., et al.. (2016). Use of the VH6-1 gene segment to code for anti-interleukin-18 autoantibodies in multiple sclerosis. Immunogenetics. 68(4). 237–246. 3 indexed citations
20.
Malkova, N A, et al.. (2011). Polymorphic locus rs10492972 of the KIF1B gene association with multiple sclerosis in Russia: Case control study. Molecular Genetics and Metabolism. 104(3). 390–394. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pierre Grammond Breakdown of academic impact, for papers by Patti Tosta Breakdown of academic impact, for papers by Sam Yuen Breakdown of academic impact, for papers by Magda Alexis Breakdown of academic impact, for papers by Amanda Gillespie-Twardy Breakdown of academic impact, for papers by Robert Galamaga Breakdown of academic impact, for papers by Meredith Little Breakdown of academic impact, for papers by Sophy Denker Breakdown of academic impact, for papers by Barbara Pro Breakdown of academic impact, for papers by Sven Mattern
Rankless by CCL
2026